This prospective study aims to determine the prevalence and utility of clinical stigmata of chronic liver disease (CLD)in a high-risk cohort. Methods: Patients with chronic hepatitis B (CHB) and hepatitis C (CHC) undergoing liver stiffness measurement (LSM) using transient elastography (Fibroscan ...
Although physicians have looked for cutaneous signs of liver disease for more than a century, their prognostic value has never been evaluated systematically. Therefore, cutaneous changes were prospectively recorded in all patients referred for liver biopsy from June 2000 to May 2004. Fibrosis was ...